Arjuna Therapeutics
ARJUNA Therapeutics develops a novel class of orally available small molecules aimed at treating currently untreatable cancers, making cancer more survivable.
About Arjuna Therapeutics
Arjuna Therapeutics, founded in 2019, is a biotechnology company developing a novel medical platform designed to help patients combat the most aggressive forms of cancer. The company’s mission is to address the significant fears associated with a cancer diagnosis such as uncertainty about treatment effectiveness, recurrence, spread, and side effects by advancing innovative therapeutic solutions. Arjuna Therapeutics aims to transform cancer care and ultimately remove the fear surrounding a diagnosis for patients and their families.



